Genetic variability of CYP2D6, CYP2C19, and CYP1A2 in patients with treatment resistance to antipsychotics and antidepressants

The study objective was to assess the frequency of gene alleles responsible for the metabolism and elimination of drugs in treatment-resistant patients to antipsychotics and/or antidepressants.

Authors

Institutions

Publication Details

Journal
Folia Medica
Published
2025-08-29
DOI
https://doi.org/10.3897/folmed.67.e149527
Citations
1
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetic variability of CYP2D6, CYP2C19, and CYP1A2 in patients with treatment resistance to antipsychotics and antidepressants

Т. А. Жиганова, Evgenia A. Radkova
1 citations
Folia Medica
Treatment of Major Depression
1.39
article

Genetic variability of CYP2D6, CYP2C19, and CYP1A2 in patients with treatment resistance to antipsychotics and antidepressants

Т. А. Жиганова, Evgenia A. Radkova
article en
1 citations

Abstract

The study objective was to assess the frequency of gene alleles responsible for the metabolism and elimination of drugs in treatment-resistant patients to antipsychotics and/or antidepressants.

Folia MedicaVol. 67(4)
European University at Saint Petersburg (RU), Saint Petersburg State Pediatric Medical University (RU)
Russian Presidential Academy of National Economy and Public Administration, NIH Clinical Center
Openalex Percentile: Top 17%
Treatment of Major Depression
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.